Related Experiment Videos

Langerhans cell histiocytosis of the sternum

Hiroyuki Tsuchie1, Kyoji Okada, Hiroyuki Nagasawa

  • 1Department of Orthopedic Surgery, Akita University School of Medicine, 1-1-1 Hondo, Akita, Japan. tsuchie@doc.med.akita-u.ac.jp

Insights

We describe a rare case of Langerhans cell histiocytosis affecting the sternum in a 12-year-old girl. Chemotherapy effectively resolved her chest pain and swelling, indicating successful treatment for this rare bone condition.

Area of Science:

  • Pediatric Oncology
  • Histiocytosis
  • Skeletal Pathology

Background:

  • Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disorder of cells resembling Langerhans cells.
  • While LCH commonly affects bones, sternal involvement is exceptionally rare.

Observation:

  • A 12-year-old female presented with anterior chest pain and swelling.
  • Imaging revealed an osteolytic sternal lesion with increased uptake on bone scintigraphy, also noted in the right femur and tibia.
  • Histopathological analysis confirmed Langerhans cell histiocytosis.

Findings:

  • The sternal lesion was diagnosed as Langerhans cell histiocytosis.
  • The patient responded well to chemotherapy, with complete resolution of symptoms.

Implications:

  • This case highlights the importance of considering LCH in pediatric patients with sternal osteolytic lesions.
  • Early diagnosis and prompt chemotherapy are crucial for favorable outcomes in sternal LCH.
  • Further research into the specific mechanisms and optimal treatment strategies for rare LCH presentations is warranted.